These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 1375120)
1. Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Schena M; Larsson LG; Gottardi D; Gaidano G; Carlsson M; Nilsson K; Caligaris-Cappio F Blood; 1992 Jun; 79(11):2981-9. PubMed ID: 1375120 [TBL] [Abstract][Full Text] [Related]
2. CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM. Osorio LM; De Santiago A; Aguilar-Santelises M; Mellstedt H; Jondal M Blood; 1997 Apr; 89(8):2833-41. PubMed ID: 9108402 [TBL] [Abstract][Full Text] [Related]
3. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Matolcsy A; Chadburn A; Knowles DM Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611 [TBL] [Abstract][Full Text] [Related]
5. H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages. Okamoto H; Nishimura H; Shinozaki A; Zhang D; Hirose S; Shirai T Jpn J Cancer Res; 1993 Dec; 84(12):1273-8. PubMed ID: 7507474 [TBL] [Abstract][Full Text] [Related]
6. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing. Wakai M; Hashimoto S; Omata M; Sthoeger ZM; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Diamond B; Dono M Autoimmunity; 1994; 19(1):39-48. PubMed ID: 7538331 [TBL] [Abstract][Full Text] [Related]
7. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia. Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943 [TBL] [Abstract][Full Text] [Related]
8. Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Mikaelsson E; Danesh-Manesh AH; Lüppert A; Jeddi-Tehrani M; Rezvany MR; Sharifian RA; Safaie R; Roohi A; Osterborg A; Shokri F; Mellstedt H; Rabbani H Blood; 2005 Jun; 105(12):4828-35. PubMed ID: 15741214 [TBL] [Abstract][Full Text] [Related]
9. Modulation and high frequency expression of autoantibody-associated cross-reactive idiotypes linked to the VHI subgroup in CD5-expressing B lymphocytes from patients with chronic lymphocytic leukaemia (B-CLL). Shokri F; Mageed RA; Richardson P; Jefferis R Scand J Immunol; 1993 Jun; 37(6):673-9. PubMed ID: 7686301 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Francia di Celle P; Mariani S; Riera L; Stacchini A; Reato G; Foa R Blood; 1996 May; 87(10):4382-9. PubMed ID: 8639799 [TBL] [Abstract][Full Text] [Related]
11. Phorbol ester activates CD5+ leukaemic B cells via a T cell-independent mechanism. Tangye SG; Weston KM; Raison RL Immunol Cell Biol; 1995 Feb; 73(1):44-51. PubMed ID: 7539402 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells. Tangye SG; Weston KM; Raison RL Leuk Lymphoma; 1998 Sep; 31(1-2):121-30. PubMed ID: 9720722 [TBL] [Abstract][Full Text] [Related]
14. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias. Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438 [TBL] [Abstract][Full Text] [Related]
15. Rapid expression of protooncogenes c-fos and c-myc in B-chronic lymphocytic leukemia cells during differentiation induced by phorbol ester and calcium ionophore. Drexler HG; Janssen JW; Brenner MK; Hoffbrand AV; Bartram CR Blood; 1989 May; 73(6):1656-63. PubMed ID: 2496772 [TBL] [Abstract][Full Text] [Related]
16. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta. Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793 [TBL] [Abstract][Full Text] [Related]
17. Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype. Segel GB; Woodlock TJ; Xu J; Li L; Felgar RE; Ryan DH; Lichtman MA; Wang N Blood Cells Mol Dis; 2003; 30(3):277-87. PubMed ID: 12737946 [TBL] [Abstract][Full Text] [Related]
18. Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis. Schettino EW; Cerutti A; Chiorazzi N; Casali P J Immunol; 1998 Jan; 160(2):820-30. PubMed ID: 9551917 [TBL] [Abstract][Full Text] [Related]
19. CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia. Mayer R; Logtenberg T; Strauchen J; Dimitriu-Bona A; Mayer L; Mechanic S; Chiorazzi N; Borche L; Dighiero G; Mannheimer-Lory A Blood; 1990 Apr; 75(7):1518-24. PubMed ID: 1690580 [TBL] [Abstract][Full Text] [Related]
20. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]